Skip to main content
  • Other Publications
  • Subscribe
  • Contact Us
Advertisement
JCORE Reference
this is the JCORE Reference site slogan
  • Home
  • Most Read
  • About Us
    • About Us
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Patients
  • Reference Site Links
    • View Regions
  • Archive

On “What makes transcutaneous electrical nerve stimulation work?...” Sluka KA, Bjordal JM, Marchand S, Rakel BA. Phys Ther. 2013;93:1397–1402.

Kayla Bergeron-Vezina, Guillaume Leonard
DOI: 10.2522/ptj.2013.93.10.1426 Published 1 October 2013
Kayla Bergeron-Vezina
K. Bergeron-Vezina, BSc, Research Center on Aging, University of Sherbrooke, Sherbrooke, Quebec, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume Leonard
G. Leonard, PT, PhD, Research Center on Aging, University of Sherbrooke, 1036, Belvedere Sud, Sherbrooke, Quebec, Canada J1H 4C4.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

[Editor's note: Both the letter to the editor by Bergeron-Vezina and Leonard and the response by Sluka and colleagues are commenting on the page proof version of the article that was published ahead of print on July 11, 2013.]

We read the article recently published by Sluka and colleagues1 in PTJ with great interest. The elements raised by the authors shed important light on the mixed results obtained in the literature concerning the analgesic effect of transcutaneous electrical nerve stimulation (TENS). In their article, Sluka and colleagues identified many factors that can affect TENS efficacy. We would like to take this opportunity to highlight 3 other important elements that can affect the analgesic effect of TENS and to remind physical therapists of the importance of considering these elements in their day-to-day practice.

Caffeine Consumption

In 1995, Marchand and colleagues2 demonstrated that caffeine could block the analgesic effect of high-frequency TENS. Monitoring caffeine intake before treatment is essential if we want to maximize the analgesic effect of TENS. Such caffeine consumption obviously includes coffee, but also other sources of caffeine (eg, tea, chocolate, energy drinks). Surprisingly, very few TENS studies published since 1995 have monitored caffeine consumption, a situation that is particularly problematic when we consider that individuals with certain chronic pain conditions tend to consume high quantities of caffeine.3 The half-life of caffeine is 4 to 6 hours.4 To ensure optimal efficacy, TENS treatment should be delayed for 6 hours after caffeine intake.

Electrode Placement

To maximize TENS analgesia, the experimenter needs to ensure good positioning of the electrodes. Current norms in research often encourage researchers to use a single and standardized electrode position for all patients. However, in order to be effective, electrode placement should be adapted individually, based on the location of the patient's pain.5,6 Electrode placement is especially important when using high-frequency TENS, a type of TENS that produces analgesia via local or segmental mechanisms.7 In such situations, the experimenter needs to be sure that the TENS-induced paresthesia appropriately covers the entire painful region.

Pain Intensity

In 1997, Benedetti and colleagues8 showed that patients with severe pain responded less positively to TENS compared with patients with mild or moderate pain. These observations indicate that the intensity of clinical pain greatly affects the efficacy of TENS. The choice of the proper treatment must be done while taking into consideration the patient's individual characteristics. Thus, TENS might not be the best treatment option for patients with high levels of pain.

Clinical Implications

Ensuring proper positioning of the electrodes and screening for caffeine consumption requires time. With their busy daily schedules, physical therapists may tend to neglect these crucial steps. They nevertheless must remember that TENS, like many other treatment modalities used in rehabilitation, requires time in order to be properly administered. By discarding certain essential steps, physical therapists run the risk of affecting negatively and lastingly the efficacy of TENS treatments.9,10

In their article, Sluka and colleagues observed that the timing of assessment is another important issue that could account for the mixed results reported in the literature. We agree with the arguments raised by the authors: the effect of TENS, like the effect of any other given intervention, should be measured during peak effect. The authors noted that the analgesic effect of TENS is maximal during TENS, an observation that also was reported by Wall and Sweet in 1967 in one of the first studies published on TENS.6 In addition to being important to research, this observation bears important consideration in clinical settings. Specifically, in patients with chronic pain, TENS should rarely (if ever) be used solely in the clinic. Instead, patients with chronic pain should be taught how to use TENS at home—a strategy that will allow these patients to take full advantage of the analgesic effect of TENS therapy.

Conclusion

Several factors must be considered when using TENS. These factors include the intensity of the TENS, its interaction with pharmacological and nonpharmacological agents, the target population, the outcomes measured, the study design, and the patient's characteristics. We thank Sluka and colleagues for their commendable article and hope that the elements raised by these authors, as well as the subjects discussed in our letter, will contribute to a better use of TENS in research and in the clinic.

Footnotes

  • This letter was posted as a Rapid Response on July 25, 2013 at ptjournal.apta.org.

  • © 2013 American Physical Therapy Association

References

  1. ↵
    1. Sluka KA,
    2. Bjordal JM,
    3. Marchand S,
    4. Rakel BA
    . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Phys Ther. 2013;93:1397–1402.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Marchand S,
    2. Li J,
    3. Charest J
    . Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation. N Engl J Med. 1995;333:325–326.
    OpenUrlCrossRefPubMed
  3. ↵
    1. McPartland JM,
    2. Mitchell JA
    . Caffeine and chronic back pain. Arch Phys Med Rehabil. 1997;78:61–63.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Benowitz NL
    . Clinical pharmacology of caffeine. Annu Rev Med. 1990;41:277–288.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Sluka KA,
    2. Walsh D
    . Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003;4:109–121.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Wall PD,
    2. Sweet WH
    . Temporary abolition of pain in man. Science. 1967;155:108–109.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Cameron MH
    . Physical Agents in Rehabilitation: From Research to Practice. 3rd ed. St Louis, MO: Saunders Elsevier; 2009:457.
  8. ↵
    1. Benedetti F,
    2. Amanzio M,
    3. Casadio C,
    4. et al
    . Control of postoperative pain by transcutaneous electrical nerve stimulation after thoracic operations. Ann Thorac Surg. 1997;63:773–776.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Leonard G,
    2. Goffaux P,
    3. Marchand S
    . Deciphering the role of endogenous opioids in high-frequency TENS using low and high doses of naloxone. Pain. 2010;151:215–219.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Leonard G,
    2. Lafrenaye S,
    3. Goffaux P
    . Randomized placebo-controlled cross-over designs in clinical trials: a gold standard to be reassessed. Curr Med Res Opin. 2012;28:245–248.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Vol 93 Issue 10 Table of Contents
Physical Therapy: 93 (10)

Issue highlights

  • Exercise Interventions for Upper Limb Dysfunction Due to Breast Cancer Treatment
  • Quality in Physical Therapist Clinical Education
  • Physical Performance in Thai Elderly People
  • Shared Decision Making in Physical Therapy
  • Kinematic and EMG Assessment of Sit-to-Stand Transfers in Patients With Stroke
  • Physical Therapy Benefit in a Typical Blue Cross Blue Shield Preferred Provider Organization Plan
  • Conceptual Limitations of Balance Measures for Community-Dwelling Older Adults
  • Validity of the Dynamic Gait Index in People With Multiple Sclerosis
  • Individual Responsiveness of 2 Measures
  • Outcome Measures for People With Stroke
  • Efficacy of TENS in the Clinical Setting
  • Self-Reported Aging-Related Fatigue
  • The Next Evolution
Email

Thank you for your interest in spreading the word on JCORE Reference.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
On “What makes transcutaneous electrical nerve stimulation work?...” Sluka KA, Bjordal JM, Marchand S, Rakel BA. Phys Ther. 2013;93:1397–1402.
(Your Name) has sent you a message from JCORE Reference
(Your Name) thought you would like to see the JCORE Reference web site.
Print
On “What makes transcutaneous electrical nerve stimulation work?...” Sluka KA, Bjordal JM, Marchand S, Rakel BA. Phys Ther. 2013;93:1397–1402.
Kayla Bergeron-Vezina, Guillaume Leonard
Physical Therapy Oct 2013, 93 (10) 1426-1427; DOI: 10.2522/ptj.2013.93.10.1426

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Save to my folders

Share
On “What makes transcutaneous electrical nerve stimulation work?...” Sluka KA, Bjordal JM, Marchand S, Rakel BA. Phys Ther. 2013;93:1397–1402.
Kayla Bergeron-Vezina, Guillaume Leonard
Physical Therapy Oct 2013, 93 (10) 1426-1427; DOI: 10.2522/ptj.2013.93.10.1426
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Caffeine Consumption
    • Electrode Placement
    • Pain Intensity
    • Clinical Implications
    • Conclusion
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • On “Benka Wallén M, Sorjonen K, Löfgren N, Franzén E. Structural validity of the Mini-Balance Evaluation Systems Test (Mini-BESTest) in people with mild to moderate Parkinson disease.” Phys Ther. 2016;96:1799–1806.
  • Author Response
  • Author Response
Show more Letters and Responses

Subjects

  • Pain

Footer Menu 1

  • menu 1 item 1
  • menu 1 item 2
  • menu 1 item 3
  • menu 1 item 4

Footer Menu 2

  • menu 2 item 1
  • menu 2 item 2
  • menu 2 item 3
  • menu 2 item 4

Footer Menu 3

  • menu 3 item 1
  • menu 3 item 2
  • menu 3 item 3
  • menu 3 item 4

Footer Menu 4

  • menu 4 item 1
  • menu 4 item 2
  • menu 4 item 3
  • menu 4 item 4
footer second
footer first
Copyright © 2013 The HighWire JCore Reference Site | Print ISSN: 0123-4567 | Online ISSN: 1123-4567
advertisement bottom
Advertisement Top